tert-Butyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate

Catalog No. :
ACJTAL427
CAS No. :
1873305-94-2
Molecular Formula :
C13H22N2O3
Molecular Weight :
254.33

IUPAC Name:tert-butyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate

tert-Butyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$157.00Login to see priceIn stockInquiry
100mg95%$282.00Login to see priceIn stockIn stock
250mg95%$453.00Login to see priceIn stockIn stock
1g95%$1136.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate
IUPAC Nametert-butyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate
Molecular FormulaC13H22N2O3
Molecular Weight254.33
SMILESO=C(N1CC2(CC(NCC2)=O)CC1)OC(C)(C)C
InChI KeyDGGGXEYLMJHIQN-UHFFFAOYSA-N
Synonym1,1-Dimethylethyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate;tert-butyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate;tert-butyl 7-oxo-2,8-diazaspiro[4.5]decane-2-carboxylate - [B84087]
CAS No.1873305-94-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACJTAL427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACITSY638 route compound structure diagram
    ACITSY6382866335-57-9 In Stock
  4. Then
  5. ACJTAL427 route product structure diagram
    ACJTAL4271873305-94-2 In Stock
Inquiry

2. ACJTAL427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJTAL427 route product structure diagram
    ACJTAL4271873305-94-2 In Stock
Inquiry

Comments (0)